Neoadjuvant Chemotherapy in Breast Cancer

  • End date
    Mar 30, 2024
  • participants needed
  • sponsor
    Center of Personalized Medicine, Pirogova
Updated on 28 March 2021


This study compares two approaches of upfront chemotherapy in breast cancer.


A Decision Support System (DSS) is an information system that supports business, medical, educational or organisational decision-making activities. DSSs fuse human knowledge and technology to support and improve decision-making.

The area of precision oncology that supports the treatment of breast cancer has not only seen an increase in the availability of different treatment choices but also genomic tools to support the decision-making process. CDSSs have been available for use in clinical oncology practice for over a decade. However, there has been some criticism around the utility of CDSS in personalised medicine decision-making of breast cancer, with these systems often viewed as aids better suited to support the 'average' patient's requirements rather than personalised treatment for the individual patient.

The purpose of the current study is to evaluate an innovative CDSS (MedicBK) platform based on the comparison of multiple treatments simultaneously in making care decisions taking into account the individual characteristics of patients, i.e., based on personalized evidence-based medicine.

Condition clinical decision support systems
Treatment Neoadjuvant Chemotherapy by CDSS (MedicBK), General practice, General practice
Clinical Study IdentifierNCT04802941
SponsorCenter of Personalized Medicine, Pirogova
Last Modified on28 March 2021


Yes No Not Sure

Inclusion Criteria

Histologically confirmed infiltrating breast cancer
Stage II or stage III disease. Nodal status must be examined by ultrasound, fine needle aspiration, sentinel node biopsy, or FDG-PET scan
Age 18
Eastern Cooperative Oncology Group performance status 1
Adequate bone marrow function (ANC >1.5 x 109/l, platelets >100 x 109/l)
Adequate hepatic function (ALAT, ASAT and bilirubin <2.5 times upper limit of normal)
Adequate renal function (creatinine clearance >50 ml/min)
LVEF 50% measured by echocardiography or MUGA
Absence of any psychological, familial, sociological, or geographical condition potentially hampering compliance with the study protocol and follow-up schedule
Absence of any medical condition that would place the patient at unusual risk
Signed written informed consent

Exclusion Criteria

previous radiation therapy or chemotherapy
other malignancy except carcinoma in situ, unless the other malignancy was treated 5 years ago with curative intent without the use of chemotherapy or radiation therapy
current pregnancy or breastfeeding. Women of childbearing potential must use adequate contraceptive protection
evidence of distant metastases. Evaluation of the presence of distant metastases may include chest X-ray, liver ultrasound, isotope bone-scan, CT-scan of chest and abdomen and/or FDG-PET scan, according to local procedures
evidence of bilateral infiltrating breast cancer. Evaluation of the presence of bilateral infiltrating breast cancer may include mammography, breast ultrasound and/or MRI breast
concurrent anti-cancer treatment or another investigational drug
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note